CHELSEA THOUVENOT: Open Payments
NPI 1083076129 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$368 in 16 payments from 6 companies in 2025. Trend: 2023 $26 · 2024 $20 · 2025 $368
Food & beverage: $368
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 8 | $159 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $65 |
| Otsuka America Pharmaceutical, Inc. | 2 | $56 |
| ABBVIE INC. | 2 | $37 |
| Indivior Inc. | 1 | $31 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
Products named: COBENFY, CAPLYTA, REXULTI, VRAYLAR, SUBLOCADE, INVEGA SUSTENNA.
Industry payments across CA — which companies pay providers there.
